Xeljanz®

INN: tofacitinib

Approved for use in:

Ulcerative Colitis (moderate-severe)

Type/Class

Oral Small Molecule (JAK inhibitor)

Delivery Route

Oral (tablet)

Health Canada Approval

2014

Storage

Store between 15 and 30°C.

Use in Older Adults (65+)

May be used, please consult your doctor.

Pregnancy Indication

Can cause fetal and maternal harm; women of reproductive potential should be advised to use contraception during treatment and for 4-6 weeks afterwards.

Breastfeeding Indication

Not recommended.

Pediatric Indication

Not used for pediatric IBD.

Learn More

View the Xeljanz® product monograph.